Atractylenolide III Ameliorates TNBS‐Induced Intestinal Inflammation in Mice by Reducing Oxidative Stress and Regulating Intestinal Flora

Increased neutrophil granulocyte and myeloperoxidase (MPO) levels indicate acute inflammation due to the exposure of zinc- and copper-containing welding fumes

(2020) Mara Reisgen et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Effects of diode laser application on inflammation and mpo in periodontal tissues in a rat model

(2018) Mustafa Özay USLU et al.   Journal of Applied Oral Science

LL202 ameliorates colitis against oxidative stress of macrophage by activation of the Nrf2/HO-1 pathway

(2018) Yuan Gao et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NFκB and Nrf-2/HO-1 signaling crosstalk

(2018) Sameh Saber et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Novel insight into the role of microbiota in colorectal surgery

(2017) Radu Bachmann et al.   GUT

Chemically induced mouse models of acute and chronic intestinal inflammation

(2017) Stefan Wirtz et al.   Nature Protocols

Anti-Inflammatory Effect of Erythropoietin in the TNBS-induced Colitis

(2016) Vanessa Mateus et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Oleic acid, hydroxytyrosol and n -3 fatty acids collectively modulate colitis through reduction of oxidative stress and IL-8 synthesis; in vitro and in vivo studies

(2016) K. Vijay Kumar Reddy et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota

(2015) C. T. Peterson et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Anti-inflammatory activity of atractylenolide III through inhibition of nuclear factor-κB and mitogen-activated protein kinase pathways in mouse macrophages

(2015) Guang-Quan Ji et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Inhibition of Chronic Ulcerative Colitis-associated Adenocarcinoma Development in Mice by VSL#3

(2015) Elena Talero et al.   INFLAMMATORY BOWEL DISEASES

Probiotics in the Management of Ulcerative Colitis

(2015) Richa Chibbar et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Host lysozyme-mediated lysis ofLactococcus lactisfacilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons

(2015) Sonia A. Ballal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Activation of TLR4 Is Required for the Synergistic Induction of Dual Oxidase 2 and Dual Oxidase A2 by IFN-  and Lipopolysaccharide in Human Pancreatic Cancer Cell Lines

(2013) Y. Wu et al.   JOURNAL OF IMMUNOLOGY

Interaction of Formyl Peptide Receptor 1 (FPR1) and Enteric Commensal Bacteria in Intestinal Homeostasis and Wound Healing

(2012) Ashfaqul Alam et al.   INFLAMMATORY BOWEL DISEASES

Epidemiology and Natural History of Inflammatory Bowel Diseases

(2011) Jacques Cosnes et al.   GASTROENTEROLOGY

Blockade of IL-6 Secretion Pathway by the Sesquiterpenoid Atractylenolide III

(2011) Tae-Hee Kang et al.   JOURNAL OF NATURAL PRODUCTS

Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model

(2010) Maria Silene da Silva et al.   JOURNAL OF ETHNOPHARMACOLOGY

Enhancement of mitomycin C-induced apoptosis in Nrf2-deficient human colon cancer cells

(2010) Jee Yeon Park et al.   Molecular & Cellular Toxicology

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

(2009) R. D. Ye et al.   PHARMACOLOGICAL REVIEWS